Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 63 Records) |
| Query Trace: Carcinoma and HCCS[original query] |
|---|
| Clinicopathologic characteristics of Wnt/?-catenin-deregulated hepatocellular carcinoma. Indian journal of cancer 2018 8 54 (4): 634-639. Verma Anuj, Bal Munita, Ramadwar Mukta, Deodhar Kedar, Patil Prachi, Goel Mahe |
| Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology (Baltimore, Md.) 2018 Aug . Li Chiao-Ling, Li Chen-Yu, Lin You-Yu, Ho Ming-Chih, Chen Ding-Shinn, Chen Pei-Jer, Yeh Shiou-Hw |
| Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening. The Journal of molecular diagnostics : JMD 2018 8 20 (6): 836-848. Paradiso Viola, Garofoli Andrea, Tosti Nadia, Lanzafame Manuela, Perrina Valeria, Quagliata Luca, Matter Matthias S, Wieland Stefan, Heim Markus H, Piscuoglio Salvatore, Ng Charlotte K Y, Terracciano Luigi |
| Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors. Hepatology communications 2018 Jun 2 (6): 718-731. Jiao Jingjing, Watt Gordon P, Stevenson Heather L, Calderone Tiffany L, Fisher-Hoch Susan P, Ye Yuanqing, Wu Xifeng, Vierling John M, Beretta Lau |
| Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma. Human pathology 2018 6 81 37-46. Lee Minho, Kim Kyung, Kim Shinn Young, Jung Seung-Hyun, Yoon Jonghwan, Kim Min Sung, Park Hyeon-Chun, Jung Eun Sun, Chung Yeun-Jun, Lee Sug Hyu |
| Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019 Aug . Grimaudo Stefania, Pipitone Rosaria Maria, Pennisi Grazia, Celsa Ciro, Cammà Calogero, Di Marco Vito, Barcellona Maria Rosa, Boemi Roberta, Enea Marco, Giannetti Aurora, Spatola Federica, Marchesini Giulio, Craxì Antonio, Petta Salvato |
| Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence. Journal of hepatology 2019 Jul . Zhou Shao-Lai, Zhou Zheng-Jun, Hu Zhi-Qiang, Song Cheng-Li, Luo Yi-Jie, Luo Chu-Bin, Xin Hao-Yang, Yang Xin-Rong, Shi Ying-Hong, Wang Zheng, Huang Xiao-Wu, Cao Ya, Fan Jia, Zhou Ji |
| Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 May . Liu Wenbin, Wu Jianfeng, Yang Fan, Ma Longteng, Ni Chong, Hou Xiaomei, Wang Ling, Xu Aijing, Song Jiahui, Deng Yang, Xian Linfeng, Li Zixiong, Wang Shuo, Chen Xi, Yin Jianhua, Han Xue, Li Chengzhong, Zhao Jun, Cao Guangw |
| Expression and significance of ETFDH in hepatocellular carcinoma. Pathology, research and practice 2019 Oct 152702. Wu Yaxun, Zhang Xingsong, Shen Rong, Huang Jieyu, Lu Xiaoyun, Zheng Guihua, Chen Xudo |
| Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection. Infectious agents and cancer 2020 6 15 37. Javanmard Davod, Najafi Mohammad, Babaei Mohammad Reza, Karbalaie Niya Mohammad Hadi, Esghaei Maryam, Panahi Mahshid, Safarnezhad Tameshkel Fahimeh, Tavakoli Ahmad, Jazayeri Seyed Mohammad, Ghaffari Hadi, Ataei-Pirkooh Angila, Monavari Seyed Hamidreaz, Bokharaei-Salim Far |
| Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross-sectional study (2016-2017). Health science reports 2020 5 3 (2): e155. Alvarez Christian S, Ortiz Jeremy, Bendfeldt-Avila Giovanna, Xie Yi, Wang Mingyi, Wu Dongjing, Higson Herbert, Lee Elisa, Teshome Kedest, Barnoya Joaquin, Kleiner David E, Groopman John D, Orozco Roberto, McGlynn Katherine A, Gharzouzi Eduardo, Dean Micha |
| Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinoma. Journal of gastrointestinal oncology 2020 3 11 (1): 112-120. Huang Ao, Wang Yu-Peng, Wang Jian, Fu Pei-Yao, Zhang Xin, Cao Ya, Fan Jia, Yang Xin-Rong, Zhou Ji |
| MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma. Cancer research 2020 2 80 (8): 1720-1734. Gramantieri Laura, Pollutri Daniela, Gagliardi Martina, Giovannini Catia, Quarta Santina, Ferracin Manuela, Casadei-Gardini Andrea, Callegari Elisa, De Carolis Sabrina, Marinelli Sara, Benevento Francesca, Vasuri Francesco, Ravaioli Matteo, Cescon Matteo, Piscaglia Fabio, Negrini Massimo, Bolondi Luigi, Fornari Frances |
| Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody. Liver cancer 2021 Jul 10 (4): 380-393. Morita Masahiro, Nishida Naoshi, Sakai Kazuko, Aoki Tomoko, Chishina Hirokazu, Takita Masahiro, Ida Hiroshi, Hagiwara Satoru, Minami Yasunori, Ueshima Kazuomi, Nishio Kazuto, Kobayashi Yukari, Kakimi Kazuhiro, Kudo Masatos |
| Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI. Cancers 2021 7 13 (14): . Kubo Akinori, Suda Goki, Kimura Megumi, Maehara Osamu, Tokuchi Yoshimasa, Kitagataya Takashi, Ohara Masatsugu, Yamada Ren, Shigesawa Taku, Suzuki Kazuharu, Kawagishi Naoki, Nakai Masato, Sho Takuya, Natsuizaka Mitsuteru, Morikawa Kenichi, Ogawa Koji, Ohnishi Shunsuke, Sakamoto Nao |
| The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular Carcinoma. Pharmacogenomics and personalized medicine 2021 6 14 723-736. He Fu, Song Kangjian, Guan Ge, Huo Junyu, Xin Yang, Li Tianxiang, Liu Chao, Zhu Qingwei, Fan Ning, Guo Yuan, Wu Liq |
| Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Journal of hepatology 2021 5 75 (4): 865-878. Pinyol Roser, Torrecilla Sara, Wang Huan, Montironi Carla, Piqué-Gili Marta, Torres-Martin Miguel, Wei-Qiang Leow, Willoughby Catherine E, Ramadori Pierluigi, Andreu-Oller Carmen, Taik Patricia, Lee Youngmin A, Moeini Agrin, Peix Judit, Faure-Dupuy Suzanne, Riedl Tobias, Schuehle Svenja, Oliveira Claudia P, Alves Venancio A, Boffetta Paolo, Lachenmayer Anja, Roessler Stephanie, Minguez Beatriz, Schirmacher Peter, Dufour Jean-François, Thung Swan N, Reeves Helen L, Carrilho Flair J, Chang Charissa, Uzilov Andrew V, Heikenwalder Mathias, Sanyal Arun, Friedman Scott L, Sia Daniela, Llovet Josep |
| Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI. Insights into imaging 2022 4 13 (1): 81. Michallek Florian, Sartoris Riccardo, Beaufrère Aurélie, Dioguardi Burgio Marco, Cauchy François, Cannella Roberto, Paradis Valérie, Ronot Maxime, Dewey Marc, Vilgrain Valér |
| Aflatoxin levels and prevalence of TP53 aflatoxin-mutations in hepatocellular carcinomas in Mexico. Salud publica de Mexico 2022 4 64 (1): 35-40. Lino-Silva Leonardo S, Lajous Martín, Brochier Marion, Santiago-Ruiz Luis, Melchor-Ruan Javier, Xie Yi, Wang Mingyi, Wu Dongjing, Higson Herbert, Jones Kristine, Romero-Martínez Martin, Villalpando Salvador, Mohar Alejandro, Smith Joshua W, Alvarez Christian S, McGlynn Katherine A, Dean Michael, Groopman Jo |
| Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection. Cancer genomics & proteomics 2022 2 19 (2): 259-269. Koh Hyun Hee, Choi Sangjoon, Park Cheol-Keun, Ha Sang Y |
| Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation. Cancer medicine 2022 2 11 (8): 1769-1786. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Kakuda Yuko, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma. BMC cancer 2022 Oct 22 (1): 1046. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. Biomarker research 2023 7 11 (1): 68. Ya-Sian Chang, Siang-Jyun Tu, Hong-Da Chen, Chin-Chun Chung, Ming-Hon Hsu, Yu-Pao Chou, Ya-Ting Lee, Ju-Chen Yen, Long-Bin Jeng, Jan-Gowth Cha |
| Preliminary radiogenomic study of hepatitis B virus-related hepatocellular carcinoma: associations between MRI features and mutations. Personalized medicine 2023 5 . Shanshan Gao, Feihang Wang, Wei Sun, Xianling Qian, Yuan Ji, Yunfeng Cheng, Xiaolin Wang, Lingxiao Liu, Ruofan Sheng, Mengsu Ze |
| Exploring the MRI and Clinical Features of P53-Mutated Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 2024 9 11 1653-1674. Jingfei Weng, Yuyao Xiao, Jing Liu, Xiaohua Liu, Yuqing He, Fei Wu, Xiaoyan Ni, Chun Ya |
| Integrative multi-omics characterization of hepatocellular carcinoma in hispanic patients. Journal of the National Cancer Institute 2024 8 . Debodipta Das, Xiaojing Wang, Yu-Chiao Chiu, Hakim Bouamar, Francis E Sharkey, Jorge E Lopera, Zhao Lai, Susan T Weintraub, Xianlin Han, Yi Zou, Hung-I H Chen, Carla R Zeballos Torrez, Xiang Gu, Matyas Cserhati, Joel E Michalek, Glenn A Halff, Yidong Chen, Siyuan Zheng, Francisco G Cigarroa, Lu-Zhe S |
| Higher inflammatory response in hepatocellular carcinoma is associated with immune cell infiltration and a better outcome. Hepatology international 2024 6 . Masanori Oshi, Kohei Chida, Arya Mariam Roy, Gabriella Kim Mann, Nan An, Li Yan, Itaru Endo, Kazuaki Taka |
| Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients. medRxiv : the preprint server for health sciences 2024 5 . Debodipta Das, Xiaojing Wang, Yu-Chiao Chiu, Hakim Bouamar, Francis E Sharkey, Jorge E Lopera, Zhao Lai, Susan T Weintraub, Xianlin Han, Yi Zou, Hung-I H Chen, Carla R Zeballos Torrez, Xiang Gu, Matyas Cserhati, Joel E Michalek, Glenn A Halff, Yidong Chen, Siyuan Zheng, Francisco G Cigarroa, Lu-Zhe S |
| Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV-related hepatocellular carcinoma risk: A system review and meta-analysis. Environmental toxicology 2024 4 . Xiaofeng Dong, Mengjie Zou, Chunxing Li, Honglin Luo, Shaoliang Zhu, Zheng Go |
| Higher Inflammatory Response in Hepatocellular Carcinoma is Associated with Immune Cell Infiltration and a Better Outcome. Research square 2024 1 . Masanori Oshi, Kohei Chida, Arya Mariam Roy, Gabriella Kim Mann, Nan An, Li Yan, Itaru Endo, Kazuaki Taka |
- Page last reviewed:Feb 1, 2024
- Content source: